Quantib® Prostate is currently 510(k) cleared by the FDA for distribution in the US. This product has been proven to conform to all requirements of the European Medical Device Regulations (2017/745) and is available in the EU and other countries.
No more switching between PACS, PSA density calculation feature and PI-RADS support; Quantib® Prostate offers one workflow including all essential prostate MRI reading features.
Semi-automated combination of bi-parametric data supports ROI determination and enables prostate lesion evaluation. AI-bolstered segmentation allows for easy and fast determination of lesion volume.
After prostate MRI assessment, a customized report is created including PSA density, quantified volumes, PI-RADS v.2.1 scoring and key images of suspicious regions.
How does artificial intelligence work? What are promising AI applications in the prostate cancer pathway? Which solutions are available now?
The benefits of AI for radiology are numerous. Tim Leiner, Professor of Radiology at the Department of Radiology, Utrecht University Medical Center in Utrecht, The Netherlands discusses how AI-powered tools can support the radiologists in their daily clinical workflow